Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Non-fatal myocardial infarction occurred in 4.7% versus 5.4% (HR 0.86)
It is not ready to inject
Patient feedback helps the doctor minimize the level of discomfort while optimizing results
The GOAL-HF1 trial (Randomized, Double-Blind, Multiple Ascending Dose, Placebo-Controlled, Multi-Center, Safety, Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Phase 1b/2a Clinical Trial With AC01 in Patients With Heart Failure With Reduced Ejection Fraction) is currently ongoing and is investigating the safety and effects of ghrelin
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
